I am a DPhil candidate in Psychiatry (supervised by Prof. Catherine Harmer, Prof. Philip Cowen, and Prof. Michael Browning) and a member of the Psychopharmacology and Emotion Research Laboratory (PERL) and the Oxford – Medical Research Council Doctoral Training Partnership.
I am interested in neurocognitive models of mood disorders and how they can explain important clinical features of depression, such as treatment effects, treatment resistance, or certain co-morbidities. My current research explores how potential novel and less established treatments for depression influence the processing of affective information. This includes non-pharmacological treatments (such as bright light exposure and mental exercises), as well as drug treatments (such as pramipexole).
I have a background in medicine as well as philosophy and cognitive science. I graduated from the Medical University of Vienna in 2015 as a medical doctor and subsequently went on to complete a master's degree in Mind, Language and Embodied Cognition at the University of Edinburgh (under the supervision of Prof. Andy Clark).
Currently, I am a member of Somerville College.
Winkler D. et al, (2019), Comprehensive Psychiatry
Kaltenboeck AK. and HARMER C., (2018), Brain and Neuroscience Advances
Hinterbuchinger B. et al, (2017), Schizophrenia research
Kaltenboeck A. et al, (2016), Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 30, 223 - 226
The Importance of Metacognitive Functioning in Individuals at Ultra-High Risk for Psychosis - A Systematic Review
Litvan Z. et al, (2016), EARLY INTERVENTION IN PSYCHIATRY, 10, 114 - 114